Status:
ACTIVE_NOT_RECRUITING
High- and Low-risk Actinic Keratosis Referrals to Secondary Care
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Tergooi Hospital
Conditions:
Actinic Keratoses
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the implementation of the General Practitioners guidelines 'Suspicious Skin Lesions' and investigated whether their publication and implementation has led to a reduction in the pr...
Detailed Description
In the Dutch healthcare system, patients are first examined by the general practitioner who decides whether a referral to a dermatologist is indicated. Both general practitioners and dermatologists ca...
Eligibility Criteria
Inclusion
- patients of 18 years and older
- referred to dermatologist for suspicion of actinic keratosis and diagnosed as actinic keratosis by the dermatologist
- treated at MaastrichtUMC+ or TergooiHospital
Exclusion
- different diagnosis than actinic keratosis
- referred by a different specialist than the general practitioner
- referred with multiple problems
- referred for a second opinion
- if the patients was treated as different diagnosis than actinic keratosis by general practitioner
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
3379 Patients enrolled
Trial Details
Trial ID
NCT05976061
Start Date
March 1 2021
End Date
December 1 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ellen Oyen
Maastricht, Netherlands